SOCS3 Promoter Hypermethylation Is a Favorable Prognosticator and a Novel Indicator for G-CIMP-Positive GBM Patients

BACKGROUND: Hypermethylation of the suppressor of cytokine signaling 3(SOCS3) promoter has been reported to predict a poor prognosis in several cancers including glioblstoma multiforme (GBM). We explored the function of SOCS3 promoter hypermethylation in GBM cohorts, including analysis of the CpG is...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Ying, Wang, Zheng, Bao, Zhaoshi, Yan, Wei, You, Gan, Wang, Yinyan, Hu, Huimin, Zhang, Wei, Zhang, Quangeng, Jiang, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954800/
https://www.ncbi.nlm.nih.gov/pubmed/24633048
http://dx.doi.org/10.1371/journal.pone.0091829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954800/
https://www.ncbi.nlm.nih.gov/pubmed/24633048
http://dx.doi.org/10.1371/journal.pone.0091829

Ejemplares similares